![John Cini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Cini
Oprichter bij
Sonnet BioTherapeutics, Inc.
Profiel
John K.
Cini was the founder of Sonnet BioTherapeutics Holdings, Inc., founded in 2011, where the title held was Chief Scientific Officer from 2020 to 2025.
Dr. Cini is the founder of Sonnet BioTherapeutics, Inc., founded in 2015, holding the title of Chief Scientific Officer starting in 2015.
Former jobs include Executive Director at Medarex, Inc. and Vice President-Discovery & Development Sciences at Outlook Therapeutics, Inc. from 2011 to 2015.
Education includes a doctorate from the University of North Texas.
Actieve functies van John Cini
| Bedrijven | Functie | Begin |
|---|---|---|
Sonnet BioTherapeutics, Inc.
 Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Oprichter | 01-01-2015 |
Eerdere bekende functies van John Cini
| Bedrijven | Functie | Einde |
|---|---|---|
| SONNET BIOTHERAPEUTICS | Oprichter | 02-12-2025 |
| OUTLOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 01-04-2015 |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Directeur/Bestuurslid | - |
Opleiding van John Cini
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
6
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
University of North Texas
 University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Outlook Therapeutics, Inc.
 Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
Sonnet BioTherapeutics Holdings, Inc.
 Sonnet BioTherapeutics Holdings, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
Kies MarketScreener 
